Sign up to save your podcasts
Or
Share E115: Benralizumab for EGPA - the MANDARA Study
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E115: Benralizumab for EGPA - the MANDARA Study
Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.
MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155
View all episodes
By Michael Putman
4.9
114114 ratings
Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.
MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
497 Listeners
Mayo Clinic Talks
298 Listeners
Rheumnow Podcast
126 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
515 Listeners
ACR on Air
69 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
The Curious Clinicians
370 Listeners
Rheumatology For The Royal College
181 Listeners
Febrile
184 Listeners
ACR Journals On Air
20 Listeners
Talking Rheumatology Spotlight
7 Listeners